Methylene Blue
Sentinel Lymph Node
Chinese Academy of SciencesSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Sentinel Lymph Node cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE University of Wisconsin, Madison | Phase 3 | BB |
Superparamagnetic Iron Oxide Vastra Gotaland Region | Phase 2 | BB |
Indocyanine Green Isabelle Henskens | Phase 3 | BB |
Tilmanocept University Hospital, Ghent | Phase 4 | B |
TECHNETIUM, TC-99M Isabelle Henskens | N/A | D |
Docetaxel Xijing Hospital | D | |
Epirubicin Xijing Hospital | D | |
ICG-nanocoll University Hospital, Ghent | N/A | D |
Same molecule, other indications
Methylene Blue is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →